Efficacy and safety of ipilimumab for treating advanced melanoma: A systematic review and meta‐analysis
Author:
Affiliation:
1. College of Pharmacy Southwest Minzu University Chengdu China
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.12802
Reference27 articles.
1. Combining Immunotherapy with Oncogene-Targeted Therapy: A New Road for Melanoma Treatment
2. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
3. Technology evaluation: ipilimumab, Medarex/Bristol‐Myers Squibb;Morse MA;Curr Opin Mol Ther,2005
4. Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
5. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Survival of patients with unfavorable prognosis cutaneous melanoma with increased use of immunotherapy agents: a population‐based study in Belgium;International Journal of Dermatology;2024-01-31
2. High CTLA-4 transcriptomic expression correlates with high expression of other checkpoints and with immunotherapy outcome;Therapeutic Advances in Medical Oncology;2024-01
3. Bidirectional regulation between tumor cell-intrinsic PD-L1 and TGF-β1 in epithelial-to-mesenchymal transition in melanoma;Translational Cancer Research;2022-10
4. Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment;BMC Cancer;2021-10-22
5. Cutaneous Events Associated with Immunotherapy of Melanoma: A Review;Journal of Clinical Medicine;2021-07-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3